Analysis and Reproducibility of 3′-Deoxy-3′-[(18)F]Fluorothymidine Positron Emission Tomography Imaging in Patients with Non -Small Cell Lung Cancer

Similar Items

• Using Radiolabeled 3′-Deoxy-3′-(18)F-Fluorothymidine with PET to Monitor the Effect of Dexamethasone on Non–Small Cell Lung Cancer
  od: McHugh, Christopher I., i dr.
  Izdano: (2018)
• The use of 3′-deoxy-3′-(18)F-fluorothymidine (FLT) PET in the assessment of long-term survival in breast cancer patients treated with neoadjuvant chemotherapy
  od: Ueberroth, Benjamin E., i dr.
  Izdano: (2019)
• Using (18)F Fluorodeoxyglucose Positron Emission Tomography (FDG PET) to Monitor Clinical Outcomes in Patients Treated with Neoadjuvant Chemo-Radiotherapy for Locally Advanced Pancreatic Cancer
  od: Choi, Minsig, i dr.
  Izdano: (2010)
• Reproducibility of 3′-Deoxy-3′-(18)F-Fluorothymidine MicroPET Studies in Tumor Xenografts in Mice
  od: Tseng, Jeffrey R., i dr.
  Izdano: (2005)
• Herpes Simplex Virus Thymidine Kinase Imaging in Mice with (1-(2’-deoxy-2’-[(18)F] fluoro-1-β-D-arabinofuranosyl)-5-iodouracil) and metabolite (1-(2’-deoxy-2’-[(18)F] fluoro-1-β-D-arabinofuranosyl)-5-uracil)
  od: Nimmagadda, S, i dr.
  Izdano: (2009)